Differences in sensitivity to new therapies between primary and metastatic breast cancer: A need to stratify the tumor response?

Cancer Med · 2023 · PMC9939226 · PMID 36098367

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Inter‐arm tests showed a trend toward superiority of the VC arm per patient, and confirmed superiority of the VC arm when tumors were considered independently.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.